US high court rules against Amgen in class action
WASHINGTON Feb 27 (Reuters) - The U.S. Supreme Court made it easier on Wednesday to bring class action lawsuits, breaking a line of rulings that had made it more difficult to sue corporate defendants collectively and perhaps obtain greater recoveries.
The case against Amgen Inc concerned what kind of evidence must be presented before companies may be the subject of class action lawsuits.
By 6-3, the court allowed a suit against Amgen to go forward in which the Connecticut Retirement Plans and Trust Funds accuses the biotechnology company of fraudulently inflating its stock price.
- Tesla says in talks with BMW over car batteries, parts
- Hagel, under pressure, resigns as defense secretary |
- Missouri grand jury has made decision in fatal shooting of black teen: report |
- Iran nuclear talks extended seven months after failing to meet deadline |
- Actor Dwight Henry eyed in New Orleans killing after arrest for theft
We are living longer but not creating financial plans to keep pace. Advisers give tips on how to make sure you don’t outlive your money. Video